GMVDW G Medical Innovations Holdings Ltd. - Warrants
G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in the United States, China, and Israel. The company's products include Prizma, a plug-and-play medical device that measures vital signs with electronic medical records functionality and clinical grade reporting standards; and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiogram data continuously for up to 14 days. It also develops Wireless Vital Signs Monitoring System, a solution that provides continuous real time monitoring of vital signs and biometrics. In addition, it offers monitoring services, including independent diagnostic testing facility monitoring and private monitoring services. G Medical Innovations Holdings Ltd was founded in 2014 and is based in Rehovot, Israel. This security was issued by G Medical Innovations Holdings Ltd. , whose common stock symbol is GMVD.
$0.88 -0.11 (-10.67%)
As of 03/21/2023 16:00:00 EST IEX book CBOE book
Security Information
Category1: US Equity
Category2: Warrants
Category3: Operating Companies
GICS sector: Health Care
Industry: Biotechnology
Index country: Israel
Country of incorporation:
IPO date: 06/25/2021
Outstanding shares: 4,350,212
Average volume: 419
Market cap: $3,377,681
Current dividend yield: 0.00%
All SEC filings: SEC Edgar Online
Annual filings: 20-F
Sedol: